OZANIMOD AS INDUCTION THERAPY IN MODERATE-TO-SEVERE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRUE NORTH STUDY
William Sandborn 1
Geert R. D'Haens 2
Douglas C. Wolf 3
Stephen B Hanauer 4
Igor Jovanovic 5
Subrata Ghosh 6
AnnKatrin Petersen 7
Steven Y Hua 7
Ji Hwan Lee 7
Lorna Charles 7
Keith Usiskin 7
Silvio Danese 8
Brian G. Feagan 9
1 University of California San Diego, San Diego, United States
2 Amsterdam University Medical Center, Amsterdam, Netherlands
3 Atlanta Gastroenterology Associates, Atlanta, United States
4 Feinberg School of Medicine, Chicago, United States
5 University Hospital Medical Centre Bezanijska Kosa, Belgrade, Serbia
6 University of Calgary, Alberta, Canada
7 Bristol-Myers Squibb Company, Princeton, United States
8 Humanitas Clinical and Research Center, Milan, Italy
9 Western University, London, Canada
Topic
IBD
Session
UEG Research Prize 2020 Session
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]